PAC INFECTO-1 C4

Contenido

REFERENCIAS


  1. Centers for disease Control and Prevention. Report of the Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. MMWR 1998; 47 (No. RR-5).

  2. Fauci AS. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988;239:617.

  3. Ho D et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-26.

  4. Mellors JW, Muñoz AJ, Giorgi JV et al. Plasma viral load and CD4+ lymphocytes as prognostic markers for HIV-1 infection. Ann Intern Med 1997;126:946-54.

  5. Moor JP et al. Co-receptors for HIV-1 entry. Curr Opin Immunol 1997;9:551-62.

  6. Palella F, Delaney K, Moorman A et al. Declining morbidity and mortality among patients with advanced human immunodeficency virus infection. N Engl J Med 1998;338:853-60.

  7. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-35.

  8. Berkley. AIDS in the developing world: An epidemiologic overview. Clin Infect Dis 1993;17 (Suppl 2): S329-36.

  9. Sistema Nacional de Vigilancia Epidemiológica. Epidemiología. No. 28, vol 14, sem 28; del 6 al 12 de julio de 1997.

  10. Piot P, Plummer FA, et al. AIDS: An international perspective. Science 1988;239:537.

  11. Levy JA. Long-term survivors of HIV infection. Hosp Pract 1994;oct:41-52.

  12. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HIV-III/LAV infection. N Engl J Med 1986;314:131-2.

  13. CDC. Revised Classification System for HIV Infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 1992;41:1-19.

  14. Cello JP, Greenberger NJ. Evaluation of AIDS-related diarrhea. Hosp Pract 1993;95-120.

  15. Hughes M et al. Monitoring plasma HIV-1 RNA levels in addition to CD4 lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997; 126:929-938.

  16. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. MMWR 1995;44:1-34.

  17. Ennis DM, Sang MS. Cryptococcal meningitis in AIDS. Hosp Pract 1993:99-112.

  18. Malone J, et al. Syphilis and neurosyphilis in a HIV-1 seropositive population: Evidence for frequent serologic relapse after therapy. Am J Med 1995;99:55-63.

  19. Wallace JI, Paauw DS, Spach DH. HIV infections in older patients: When to suspect the unexpected. Geriatrics 1993;48:61-70.

  20. Chang et al. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266:1865-9.

  21. CONASIDA. Guía para la atención médica de pacientes con infección por VIH/SIDA en consulta externa y hospitales. Tercera Edición. México, 1997.

  22. Bach MC, Godofsky EW. Indinavir nephrolithiasis in warm climates. Letters To The Editor. J AIDS and Hum Retrov 1997;14, No. 3.

  23. Havlir DV, Richman DD. Viral dynamics of HIV: Implications for drug development and therapeutic strategies. Ann Intern Med 1996; 124:984-994.

  24. Connor EM et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.

  25. USPH/IDSA Prevention of Opportunistic Infections Working Group: 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1997;46 (No. RR-12): 1-46.

  26. Stacker T, Collier A, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-264.

  27. Tindall B, Cooper D. Primary HIV infection: Host responses and intervention strategies. AIDS 1991; 5:1-14.

  28. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol. 1997:176:478-489.

  29. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Traits Group 320 Study Section. N Engl J Med 1997;337:734-739.

  30. Bartlett J. Protease inhibitors for HIV infection. Ann Intern Med 1996; 124:1086-1088.

  31. Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:223-31.

  32. Landay A, Ohlsson-Wilhem B, Giorgi JV. Application of flow cytometry to the study of HIV infection. AIDS 1990;4:479-97.

Contenido

Copyright © 2005 Dr. Scope. Derechos Reservados.
Diseño y Programación: Educación Médica Contínua